Casirivimab + imdevimab (Ronapreve)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- April 2023
Comments
DNP: NICE TA878 -
Casirivimab plus imdevimab is not recommended, within its marketing authorisation, for treating acute COVID‑19 in adults.search again
